Морфологическая и иммуногистохимическая оценка злокачественности опухолей щитовидной железы
Диссертация
Вместе с тем, совместная работа сотрудников клинико-морфологического отдела Учреждения Российской академии медицинских наук Медицинского радиологического научного центра РАМН (МРНЦ РАМН) с иностранными коллегами в рамках международного Проекта «Создание в странах СНГ постчернобыльского банка ткани щитовидной железы, крови, нуклеиновых кислот и базы данных» позволила выделить достаточно большую… Читать ещё >
Список литературы
- Абросимов А.Ю. Клеточные онкогены и антионкогены в опухолях щитовидной железы. // Арх. пат. 1997. — Т. 59. — Вып. 1. — С. 64−69.
- Абросимов А.Ю., Шкурко О. А. Анализ экспрессии циклина D1 в папиллярных микрокарциномах щитовидной железы. // Рос. онкол. журн. -2008. -№ 3. С. 26−30.
- Афанасьева 3. А., Петров С. В., Хасанов Р. Ш. Иммуноморфологические исследования в диагностике опухолей щитовидной железы. // Рос. онкол. журн. 2005. — № 5. — С. 50−54.
- Богданова Т.И., Козырицкий В. Г., Тронько Н. Д. Патология щитовидной железы у детей: Атлас. Киев: Чернобыльинтеринформ, 2000. — 160 С.
- Бронштейн М.Э. Цитологическая диагностика заболеваний щитовидной железы. // Пробл. эндокринол. 1997. — Т. 43. — № 3. — С. 30−38.
- Валдина Е.А. Заболевания щитовидной железы, 2-е изд. СПб. Питер, 2001.-416 с.
- Воронецкий И.Б. Ранний рак и узловые образования щитовидной железы: Автореф. дис.. канд. мед. наук. -М., 1980. 30 с.
- Гарькавцева Р.Ф., Казубская Т. П., Лиснянский И. Е. и др. Генетические аспекты рака щитовидной железы. // Пробл. эндокринол. 2002. — Т. 48. — № 4.-С. 16−20.
- Гольдбурт Н.Н. Опухоли щитовидной железы. В кн.: «Патологоанатомическая диагностика опухолей человека»: Руководство в 2-х томах. Том 2 / Под ред. Н. А. Краевского, А. В. Смольянникова, Д. С. Саркисова. — М.: Медицина, 1993. — С.349−367.
- Ю.Демидчик Л. Е., Демидчик Е. П., Фридман М. В. и др. Роль первичного морфологического диагноза папиллярного рака щитовидной железы. // Вопросы онкологии-2009.-Т.55.-№ 3.-С.351−7.
- Казанцева И.А., Федосенко А. К., Гуревич Л. Е. Иммуногистохимические исследования в дифференциальной диагностике доброкачественных излокачественных поражений щитовидной железы. // Арх. пат. 2001. — Т. 63.-Вып. 4.-С. 18−21.
- Лушников Е.Ф., Втюрин Б. М., Цыб А.Ф. Микрокарцинома щитовидной железы. М.: Медицина, 2003. — 264 с.
- Лушников Е.Ф., Цыб А.Ф., Ямасита С. Рак щитовидной железы в России после Чернобыля. — М.: Медицина, 2007. 128 с.
- Майор Н.Н., Цодикова Л. Б. Пункционная цитологическая диагностика заболеваний щитовидной железы: возможности и ограничения метода. // Арх. пат. -1996. Т. 58. — Вып. 2. — С. 74−79.
- Пальцев М.А., Коган Е. А., Тунцова О. И. Иммуногистохимия биомолекулярных маркеров раннего рака щитовидной железы. // Арх. пат. 1997. — Т. 59. — Вып. 6. — С. 18−23.
- Пальцев М.А., Коган Е. А., Тунцова О. И. и др. Морфологическая и молекулярно-генетическая характеристика рака, аденом и окружающей ткани щитовидной железы. // Арх. пат. 1998. — Т. 60. — Вып. 3. — С. 5−10.
- Свиридова Т.Е., Коган Е. А., Пальцев М. А., Середин В. П. Гистологические и молекулярно-биологические маркеры злокачественности в различных вариантах папиллярного рака щитовидной железы. // Арх. пат. 2002. — Т.64. — Вып. 6. — С. 19−23.
- Сдвижков A.M., Демидов В. П., Касаткин Ю. Н. Спорные и нерешенные вопросы в диагностике и лечении предрака и рака щитовидной железы. // Рос. онкол. журн. 2004. -№ 5. — С. 15−21.
- Хмельницкий O.K. Цитологическая и гистологическая диагностика заболеваний щитовидной железы: Руководство. СПб.: Сотис, 2002. — 288 с.
- Цыб А.Ф., Паршин B.C., Нестайко Г. В. и др. Ультразвуковая диагностика заболеваний щитовидной железы. М.: Медицина, 1997. — 332 с.
- Чазова Н.Л., Перчук Б. Д., Гольдбурт Н. Н. и др. Некоторые спорные вопросы верификации и классификации опухолей щитовидной железы. // Арх. пат. 1997. — Т. 59. — Вып. 1. — С. 33−36.
- Черствой Е.Д., Неровня A.M. Опухоли щитовидной железы. В кн.:I
- Опухоли и опухолеподобные процессы у детей". Минск: Асар, 2002. -С. 263−274.
- Чипышева Т.А., Бронштейн М. И., Ермилова В. Д., Гельштейн В. И. Иммуноморфологическая характеристика инфильтративного роста высокодифференцированных карцином щитовидной железы. // Арх. пат. — 2002. Т. 64. — Вып. 3. — С. 20−25.
- Шапиро Н.А., Камнева Т. Н. Цитологическая диагностика заболеваний щитовидной железы: Цветной атлас. М.: Репроцентр, 2002. — 172 с.
- Юшков П.В., Антонова С. С., Бартолаззи А. Галектин-3 в дифференциальной диагностике и прогнозировании фолликулярных опухолей щитовидной железы. // Арх. пат. — 2004. — Т. 66. Вып. 6. — С. 39−42.
- Abrosimov A., Saenko V., Meirmanov S. et al. The cytoplasmic expression of MUC1 in papillary thyroid carcinoma of different histological variants and its correlation with cyclin D1 overexpression. // Endocr. Pathol. 2007. — V. 18. — N. 2.-P. 68−75.
- Agarwal S., Mathur SR., Ray R. et al. Cytopathological diagnosis of hyalinizing trabecular tumor, a rare thyroid neoplasm. // Cytopathology.-2009.-V.37.-N.7.-P.455−57.
- Ahn SS., Kim EK., Kang DR. et al. Biopsy of thyroid nodules: comparison of three sets of guidelines. // Am. J. Roentgenol.-2010 V.194.-N.1-P.31−7.
- Anderson CE., Graham C., Herriot MM. et al. CD 98 expression is decreased in papillary carcinoma of the thyroid and Hashimoto’s thyroiditis. // Histopathology.-2009.-V.55.-N.6-P.683−6.
- Antonaci A., Consorti F., Mardente S., Giovannone G. Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma. // Oncol. Res.-2009.-V.17.-N.10.-P.495−503.
- Arora N., Scognamiglio Т., Zhu В., Fahey Iii T.J. Do benign thyroid nodules have malignant potential? An evidence-based review. // World J.Surg. 2008. -V. 32.-N. 7.- P. 1237−1246.
- Arora N., Scognamiglio Т., Lubitz CC. et al. Identification of borderline thyroid tumors by gene expression array analysis. //Cancer.-2009.-V.l 15.-N.23.-P.5421−31.
- Asa SL. My approach to oncocytic tumors of the thyroid. // J. Clin. Pathol.-2004.-V.57.-N.3.-P. 225−32.
- Asa S. The role of immunohistochemical markers in the diagnosis of follicular patterned lesions of the thyroid. // Endocrine Pathol. 2005. — V. 16. — P. 295 309.
- Baloch Z.W., Abraham S., Roberts S., LiVolsi V.A. Differential expression of cytokeratin in follicular variant of papillary carcinoma: an immunohistocchemical study and its diagnostic utility. // Hum. Pathol. 1999. -V. 30.-P. 1166−1171.
- Baloch ZW., LiYolsi VA. Etiology and significance of the optically clear nucleus. //Endocr. Pathol.-2002.-V.13.-N.4.-P.289−99.
- Baloch ZW., LiVolsi VA. Our approach to follicular-patterned lesions of the thyroid. // J. Clin. Pathol.-2007.-V.60.-N.3.-P.244−50.
- Barden C.B., Shister K.W., Zhu B. et al. Classification of follicular thyroid tumors by molecular signature: results of gene profiling. // Clin. Cane. Res. — 2003. V. 9. — N. 5. — P. 1792−1800.
- Beesley MF., McLaren KM. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. // Histopathology.-2002.-V.41 .-N.3 .-P.23 6−43.
- Beige G., Meyer A., Klemke M. et al. Upregulation of HMGA2 in thyroid carcinomas: a novel molecular marker to distinguish between benign and malignant follicular neoplasias. // Genes, chromosomes and cancer. 2008. -V. 47.-N. l.-P. 56−63.
- Boerner SL., Asa SL. Hyalinizing trabecular tumor of the thyroid gland: much ado about nothing? // Am. J. Surg. Pathol.-2004.-V.122.-N.4.-P.495−6.
- Bryson P.C., Shores C.G., Hart C. et al. Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. // Arch. Otolaryngol. Head Neck Surg. 2008. — V. 134. — N. 6. — P. 581−586.
- Bukhari U., Sadiq S., Kehar SI. Differential expression of CK 19 in follicular adenoma, well-differentiated tumor of uncertain malignant potential (WDT-UMP) and follicular variant of papillary carcinoma.//J. Рак. Med. Assoc.2009.-V.59.-N. l.-P. 15−8.
- Cameron BR., Berean KW. Cytokeratin subtypes in thyroid tumors: immunohistochemical study with emphasis on the follicular variant of papillary carcinoma. //J. Otolaryngol.-2003.-V.32.-N.5.-P.319−22.
- Carney J.A. Hyalinizing trabecular tumors of the thyroid gland: quadruply described but not by the discoverer. // Am. J. Surg. Pathol. 2008. — V. 32. -N. 4.-P. 622−634.
- Carney J.A., Ryan J., Goellner J.R. Hyalinizing trabecular adenoma of the thyroid gland. //Am. J. Surg. Pathol. 1987. -V. 11. -N. 8. — P. 583−591.
- Casey M.B., Lohse C.M., Lloyd R.V. Distinction between papillary thyroid hyperplasia and papillary thyroid carcinoma by immunohistochemical staining for cytokeratin 19, galectin 3 and HBME 1. // Endocrine Pathol. 2003. — V. 14. -P.55−60.
- Casey MB., Sebo TJ., Carney JA. Hyalinizing trabecular adenoma of the thyroid gland: cytologic features in 29 cases. // Am. J. Surg. Pathol.-2004.-V.28.-N.7.-P.859−67.
- Cerutti J.M., Delcelo R., Amadei M J. et al. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression. // J. Clin. Invest. -2004. V. 113.-N. 8.-P. 1234−1242.
- Chebib I., Opher E., Richardson ME. Vascular and capsular pseudoinvasion in thyroid neoplasms. //Int. J. Surg. Pathol.-2009.-v.l7.-N.6.-P.449−51.
- Cheung C.C., Boerner S.L., MacMillan C.M. et al. Hyalinizing trabecular tumor of the thyroid: a variant of papillary carcinoma proved by molecular genetics. // Am. J. Surg. Pathol. 2000. — V. 24. — N. 12. — P. 1622−1626.
- Cheung CC., Ezzat S., Freeman JL. Et al. Immunohistochemical diagnosis of papillary thyroid carcinoma. // Mod. Pathol.-2001.-V.14.-N.4.-P.338−41.
- Cheung L., Messina M., Gill A. et al. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas. // J. Clin. Endocrinol. Metab. 2003. — V. 88. — N. 1. — P. 354−357.
- Chevillard S., Ugolin N., Vielh P. et al. Gene expression profiling of differentiated thyroid neoplasms: diagnostic and clinical implications. // Clin. Cane. Res. 2004. — V. 10. — N. 19. — P. 6586−6597.
- Coli A., Bigotti G., Zucchetti F. et al. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. // Histopathol. 2002. — V. 40. — N. 1. — P. 80−87.
- Das DK., Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor? //Diagn. Cytopathology.-2009.-V.37.-N.7.-P.534−41.
- De Matos PS., Ferreira AP., de Oliveira Facuni F. et al. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. // Histopathology.-2005.-V.47.-N.4.-P.391−401.
- De Micco C., Ruf J., Chrestian M.A. et al. Immunohistochemical study of thyroid peroxidase in normal, hyperplastic, and neoplastic human thyroid tissues. // Cancer. 1991. — V. 67. — N. 12. — P. 3036−3041.
- De Micco C., Vasko V., Garcia S. et al. Fine-needle aspiration of thyroid follicular neoplasm: diagnostic use of thyroid peroxidase immunocytochemistry with monoclonal antibody 47. // Surgery. 1994. — V. 116.-P. 1031−1035.
- Durand S., Ferraro-Peyret C., Selmi-Ruby S. et al. Evaluation of gene expression profiles in thyroid nodule biopsy material to diagnose thyroid cancer. // J. Clin. Endocrinol. Metab. 2008. — V. 93. — N. 4. — P. 1195−1202.
- Eszlinger M., Krohn К., Hauptmann S. et al. Perspectives for improved and more accurate classification of thyroid epithelial tumors. // J. Clin. Endocrinol. Metab. 2008. — V. 93. — N. 9. — P. 3286−3294.
- Eszlinger M., Krohn K., Kukulska A. et al. Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors. // Endocrine Reviewes. 2007. — V. 28. — P. 322−338.
- Evenson A., Mowschenson P., Wang H. et al. Hyalinizing trabecular adenoma an uncommon thyroid tumor frequently misdiagnosed as papillary or medullary thyroid carcinoma. // Am. J. Surg. Pathol.-2007.-V.193.-N.6.-P. 707−12.
- Fan Y., Shi L., Dong et al. Discovery and identification of potential biomarkers of papillary thyroid carcinoma. // Mol. Cancer.-2009.-N.8.-P.79.
- Finley D.J., Lubitz C.C., Wei C. et al. Advancing the molecular diagnosis of thyroid nodules: defining benign lesions by molecular profiling. // Thyroid. -2005. V. 15. -N. 6. — P. 562−568.
- Fischer S., Asa S.L. Application of immunohistochemistry to thyroid neoplasms.//Arch. Pathol. Lab. Med.-2008.-V. 132.-N. 3.-P. 359−372.
- Fonseca E., Nesland J.M., Sobrinho-Simoes M. Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. // Histopathol. 1997. -V. 31.-N. 4.-P. 330−335.
- Fonseca E., Soares P., Cardoso-Oliveira M., Sobrinho-Simoes M. Diagnostic criteria in well-differentiated thyroid carcinomas. // Endocr. Pathol. 2006. -V. 17.-N. 2.-P. 109−117.
- Fontaine J.F., Mirebeau-Prunier D., Franc B. et al. Microarray analysis refines classification of non-medullary thyroid tumours of uncertain malignancy. // Oncogene. 2008. — V. 27. — N. 15. — P. 2228−2236.
- Foukakis Т., Gusnanto A., Au A.Y.M. et al. A PCR-based expression signature of malignancy in follicular thyroid tumors. // Endocrine-Related Cancer. 2007. — V. 14. -N. 2. — P. 381−391.
- Fryknas M., Wickenberg-Bolin U., Goransson H. et al., Molecular markers for discrimination of benign and malignant follicular thyroid tumors. // Tumour Biol. 2006. — V. 27. — N. 4. — P. 211−220.
- Fukushima M., Ito Y., Hirokawa K. et al. Macrofollicular variant of papillary thyroid carcinoma: its clinicopathological features and long-term prognosis. // Endocr. J.-2009.- V.56.- N.3.-P.503−8.
- Gaffney R.L., Carney J.A., Sebo T.J. et al. Galectin-3 expression in hyalinizing trabecular tumors of the thyroid gland. // Am. J. Surg. Pathol. -2003. V. 27. — N. 4. — P. 494−498.
- Carney JA., Hirokawa M., Lloyd RV. Et al. Hyalinizing trabecular tumor of the thyroid gland are almost all benign. // Am. J. Surg. Pathol.-2008.-V.32.-N.12.-P.1877−89.
- Guyetant S., Michalak S., Valo I., Saint-Andre JP. Diagnosis of the follicular variant of papillary thyroid carcinoma. Significance of immunohistochemistry. //Ann. Pathol.-2003 .-V.23 .-N. 1 .-P. 11−20.
- Hamada A., Mankovskaya S., Saenko V. et al. Diagnostic usefulness of PCR profiling of the differentially expressed marker genes in thyroid papillary carcinomas. // Cancer Lett. 2005. — V. 224. — N. 2. — P. 289−301.
- Herrmann M.E., LiVolsi V.A., Pasha T.L. et al. Immunohistochemical expression of galectin-3 in benign and malignant thyroid lesions. // Arch. Pathol. Lab. Med. -2002. V. 126.-N. 6.-P. 710−713.
- Hirokawa M., Carney J.A. Cell membrane and cytoplasmic staining for MIB-1 in hyalinizing trabecular adenoma of the thyroid gland. // Am. J. Surg. Pathol. 2000. — V. 24. — N. 4. — P. 575−578.
- Hirokawa M., Carney A., Ohtsuki Y. Hyalinizing trabecular adenoma and papillary carcinoma of the thyroid gland express different cytokeratin patterns. // Am. J. Surg. Pathol. 2000. — V. 24. — N. 6. — P. 877−881.
- Hofman V., Lassalle S., Bonnetaud C. et al. Thyroid tumors of uncertain malignant potential: frequency and diagnostic reproducibility. // Virchows Arch.-2009.-V.455.-Nl.-P.21−33.
- Hunt J.L., Baloch Z.W., Barnes L. et al. Loss of heterozygosity mutations of tumor suppressor genes in cytological atypical areas in chronic lymphocytic thyroiditis. // Endocr. Pathol. 2002. — V. 13. — P. 321−330.
- Ito Y., Yoshida H., Tomoda C. et al. Galectin-3 expression in follicular tumours: an immunohistochemical study of its use as a marker of follicular carcinoma. // Pathol. 2005. — V. 37. — P. 296−298.
- Jakubiak-Wielganowicz M., Kubiak R., Sygut J. et al. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. // Pol. J. Pathol.-2003.-V.54.-N.2.-P.l 11−5.
- Jakubowski M., Hunt JL. BRAF mutational analysis in papillary carcinomas with mixed follicular and papillary growth patterns. // Am. J. Surg. Pathol.-2009.-V.33.-N.il.-P.1590−3.
- Kaleem Z., Davila R.M. Hyalinizing trabecular adenoma of the thyroid. A report of two cases with cytologic, histologic and immunohistochemical findings. // Acta Cytologica. 1997. — V. 41. — P. 883−888.
- Katoh R., Jasani В., Williams E.D. Hyalinizing trabecular adenoma of the thyroid. A report of three cases with immunohistochemical and ultrasrtuctural studies. // Histopathoi. 1989. — V. 15. — P. 211−224.
- Kebebew E., Peng M., Reiff E. et al. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. // Ann. Surg. 2005. — V. 242. — P. 353−363.
- Kebebew E., Peng M., Reiff E., McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. // Cancer. 2006. — V. 106. -P. 2592−2597.
- Kim K.H., Suh K.S., Kang D.W., Kang D.Y. Mutations of the BRAF gene in papillary thyroid carcinoma and in Hashomoto’s thyroiditis. // Pathol. Int. -2005. V. 55. — N. 9. — P. 540−545.
- Kim M.J., Kim H.J., Hong S. J et al. Diagnostic utility of galectin-3 in aspirates of thyroid follicular lesions. // Acta Cytologica. 2006. — V. 50. — N. l.-P. 28−34.
- Kovacs R.B., Foldes J., Winkler G. et al. The investigation of galectin-3 in diseases of the thyroid gland. // Eur. J. Endocrinol. 2003. — V. 149. — P. 449 453.
- Krause K., Eszlinger M., Gimm O. et al. TFF-3-based candidate gene discrimination of benign and malignant tumors in a region with borderline iodine deficiency. // J. Clin. Endocrinol. Metab. 2008. — V. 93. — N. 4. — P. 1390−1393.
- Lai G., Padmanabha L., Nicholson R. et al. // ECM1 expression in thyroid tumors a comparison of real-time RT-PCR and IHC. // J. Surg. Res. — 2008. -V. 149.-P. 62−68.
- Liang HS., Zhong YH., Luo ZJ. Et al. Comparative analysis of protein expression in differentiated thyroid tumors: a multicentre study. // J. Int. Med. Res.-2009.-V.37.-N.3.-P.927−38.
- Liu J., Singh В., Tallini G. et al. Follicular variant of papillary thyroid carcinoma: a cliniopathologic study ofa problematic entity. // Cancer.-2006.-V.107.-N.6-P. 1255−64.
- LiVolsi V.A. Hyalinizing trabecular tumor of the thyroid: adenoma, carcinoma or neoplasm of uncertain malignant potential? // Am. J. Surg. Pathol.-2000.-V. 24.-N. 12.-P. 1683−1684.
- LiVolsi V.A. Surgical Pathology of the Thyroid. Philadelphia: Saunders, 1990.- 422 p.
- LiVolsi V.A., Baloch Z.W. Follicular neoplasms of the thyroid: view, biases, and experiences. // Adv. Anat. Pathol.-2004.-V.l 1.-N.6.-P.279−87.
- Lloyd R.V. Hyalinizing trabecular tumors of the thyroid: a variant of papillary carcinoma? // Adv. Anat. Pathol. 2002. — V. 9. -N. 1. — P. 7−11.
- Lloyd R.V. Distinguishing benign from malignant thyroid lesions: galectin-3 as the latest candidate. // Endocr. Pathol.-2001.-V.12.-N.3.-P.255−7.
- Lopez-Penabad L., Chiu AC., Hoff AO. Et al. Prognostic factors in patient with Hurthle cell neoplasms of the thyroid. //Cancer.-2003.-V.97.-N.5.-P. 1186−94.
- Lubitz C.C., Ugras S.K., Jacob Kazam J. et al., Microarray analysis of thyroid nodule fme-needle aspirates accurately classifies benign and malignant lesions. // J. Mol. Diagn. 2006. — V. 8. — P. 490−498.
- Lumachi F., Borsato S., Tregnahi A. et al. FNA cytology and frozen section examination in patients with follicular lesions of the thyroid gland. // Anticancer Res.-2009.-V.29.-N.12.-P.5255−7.
- McCluggage W.G., Sloan J.M. Hyalinizing trabecular carcinoma of thyroid gland. // Histopathology. -1996. V. 28. — P. 357−362.
- Mehrotra P., Okpokam A., Bouhaidar R. et al. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. // Histopathol. 2004. -V. 45.-N. 5.-P. 493−500.
- Meirmanov S., Nakashima M., Kondo H. et al. Correlation of cytoplasmic beta-catenin and cyclin D1 overexpression during thyroid carcinogenesis around Semipalatinsk nuclear test site. // Thyroid.-2003.-Y.13.-N.6.-P.537−45.
- Mills L.J., Poller D.N., Yiangou C. Galectin-3 is not useful in thyroid FNA. // Cytopathol. -2005. V. 16.-P. 132−138.
- Molberg K., Albores-Saavedra J. Hyalinizing trabecular carcinoma of the thyroid gland. // Hum. Pathol. 1994. — V. 25. — P. 192−197.
- Musholt PB., Musholt TJ., Morgestem SC. Et al. Follicular histotypes of oncocytic thyroid carcinoma do not carry mutations of the BRAF hot-spot. //World J. Surg.-2008.-V.32.-N.5.-P. 722−8.
- Nakamura N., Carney J.A., Jin L. et al. RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors // Lab. Invest. -2005.-V. 85.-N. 9.-P. 1065−1075.
- Nakamura N., Erickson LA., Jin L. et al. Immunohistochemical separation of follicular variant of papillary carcinoma from follicular adenoma. // Endocr. Pathol.-2006.- V.17.-N.3.-P. 213−23.
- Nakashima M., Meirmanov S., Naruke Y. et al. Cyclin D1 overexpression in thyroid tumors from a radio-contaminated area and its correlation with Pinl and aberrant beta-catenin expression.// J. Pathol.-2004.-V.202.-N.4.-P.446−55.
- Nakazawa Т., Murata S., Kondo T. et al. RET/PTC rearragements arising from a small population of papillary thyroid carcinoma cells, possible candidate for passenger mutation. // Virchows Arch.-2009.-V.455.-N.1.-P.35−41.
- Nascimento M.C., Bisi H., Alves V.A. et al. Differential reactivity for galectin-3 in Hurthle cell adenomas and carcinomas // Endocr. Pathol. 2001. -V. 12.-N.3.-P. 275−279.
- Nasr MR., Mukhopadhyay S., Zhang S., Katzenstein AL. Absence of the BRAF mutation in HBME-1 + and CK 19+ atypical cell clusters in Hashimoto thyroiditis: supportive evidence against preneoplastic change. // Am. J. Pathol. -2009.-V.132.-N.6.-P.906−12.
- Niedziela M., Maceluch J., Korman E. Galectin-3 is not an universal marker of malignancy in thyroid nodular disease in children and adolescents. // J. Clin. Endocrinol. Metab. 2002. — V. 87. — N. 9. — P. 4411−4415.
- Nikiforov YE. RET/PTC rearrangement in thyroid tumors. // Endocr. Pathol.-2002.-V. 13 .-N. 1 .-P.3−16.
- Nikiforova M.N., Biddinger P.W., Caudill C.M. et al. PAX8-PPAR gamma rearrangement in thyroid tumors. RT-PCR and immunohistochemical analyses. // Am. J. Surg. Pathol. 2002. — V. 26. — N. 8. — P. 1016−1023.
- Nikiforova M.N., Caudill C.M., Biddinger P., Nikiforov Y.E. Prevalence of RET/PTC rearrangements in Hashimoto’s thyroiditis and papillary thyroid carcinomas. // Int. J. Surg. Pathol. 2002. — V. 10. — P. 15−22.
- Oestreicher-Kedem Y., Halpern M., Roizman P. et al. Diagnostic value of galectin-3 as a marker for malignancy in follicular patterned thyroid lesions. // Head Neck. 2004. — V. 26. — N. 11. — P. 960−966.
- Pagedar N.A., Chen D.H., Wasman J.K. et al. Molecular classification of thyroid nodules by cytology. Laryngoscope. — 2008. — V. 118. — N. 4. — P. 692−696.
- Papotti M., Riella P., Montemurro F. et al. Immunophenotypic heterogeneity of hyalinizing trabecular tumours of the thyroid. // Histopathol. -1997.-V. 31.-N. 6.-P. 525−533.
- Papotti M., Rodriguez J., De Pompa R. et al. Galectin-3 and HBME-1 expression in well differentiated thyroid tumors with follicular architecture of uncertain malignant potential. // Mod. Pathol. 2005. — V. 18. -N. 4. — P. 541 546.
- Papotti M., Volante M., Giuliano A. et al. RET/PTC activation in hyalinizing trabecular tumors of the thyroid. // Am. J. Surg. Pathol. 2000. -V. 24.-N. 12.-P. 1615−1621.
- Papotti M., Volante M., Saggioratto E. et al. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. // Eur. J. Endocrinol. 2002. — V. 147. — P. 515−521.
- Park Y.J., Kwak S.H., Kim D.C. Diagnostic value of galectin-3, HBME-1, cytokeratin 19, high molecular weight cytokeratin, cyclin D1 and p27kipi in the differential diagnosis of thyroid nodules. // J. Korean Med. Sci. 2007. — V. 22.-N. 4.-P. 621−628.
- Pathology and genetics of tumours of endocrine organs. World Health Organization Classification of Tumours. Eds. R.A. DeLellis et al. Lyon: IARC Press, 2004.-P. 49−123.
- Poloz TL., Shkurupiy Va. Potentialities of differential immunohistochemical diagnosis of some follicular tumors of the thyroid gland. // Bull. Exp. Biol. Med.-2008.-v.l46.-N.6.-P.794−6.
- Prasad M., Huang Y., Pellegata N.S. et al. Hashimoto’s thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC. // Histopathol. 2004. — V. 45. — P. 39−46.
- Prasad M.L., Pellegata N.S., Huang Y. et al. Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors. // Mod. Pathol. 2005. — V. 18. — N. l.-P. 48−57.
- Prasad N.B., Somervell H., Tufano R.P. et al. Identification of genes differentially expressed in benign versus malignant thyroid tumors. // Clin. Cancer Res.-2008.-V. 14.-N. 11.-P. 3327−3337.
- Raphael S.J., McKeown-Eyssen G., Asa S.L. High molecular weight cytokeratin and cytokeratin 19 in the diagnosis of thyroid tumors. // Modern Pathol. 1994. — V. 7. — P.295−300.
- Rezk S., Brynes RK., Nelson V. et al. beta-Catenin expression in thyroid follicular lesions: potential role in nuclear envelope changes in papillary carcinomas. // Endocr. Pathol.-2004.-V.14.N.4.-P.329−37.
- Rivera M., Ricarte-Filho J., Patel S. et al. // Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. // Hum Patol.-2010.-V.41.-N.2.-P. 172−80.
- Rosai J. Ackerman’s Surgical Pathology. 9th Ed. — St. Louis, 2004. — V. l.-P. 515−594.
- Rosai J. The encapsulated follicular variant of papillary thyroid carcinoma: back to the drawing board. // Endor. Pathol. 2010.-V.13.-N.4.-P.289−99.
- Rosai J. Handling of thyroid follicular patterned lesions. // Endocr. Pathol. -2005. V. 16. — N. 4. — P. 279−283.
- Rosai J., Carcangiu M.L., DeLellis R.A. Tumors of the thyroid gland: Atlas of tumor pathology. Armed Forces Institute of pathology, Washington, DC, 1992.-343 p.
- Rosen J., He M., Umbricht C. et al. A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expression. // Surgery.-2005.-V. 138.-N. 6.-P. 1050−1056.
- Rossi ED., Raffaelli M., Mile’A. et al. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinoma from hyperfunctioning lesions of the thyroid. // Histopathology.-2006.-V.46.-N.7.-P. 795−800.
- Sack M., Astengo-Osuna C., Lin B.T. et al. HBME-1 immunostaining in thyroid fine needle aspirations: a useful marker in the diagnosis of carcinoma. //ModernPathol. 1997. -V. 10. — P. 668−674.
- Saggiorato E., Aversa S., Deandreis D. et al. Galectin-3: presurgical marker of thyroid follicular epithelial cell derived carcinoma. // Endocrinol. Invest. -2004.-V. 27.-P. 311−317.
- Sahoo S., Hoda SA., Rosai J., DeLellis RA. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution. // Am. J. Clin. Pathol.-2001.-V.l 16.-N.5.-P.696−702.
- Saleh HA., Feng J., Tabassum F. et al. Differential expression of galectin-3, CK 19, HBME-1, and Ret oncoprotein in the diagnosis of thyroid neoplasms by fine needle aspiration biopsy. // Cytojornal.2009.-N.6.-P.18.
- Savin S., Cvejic D., Isic T. et al. Thyroid peroxidase and galectin-3 immunostaining in differentiated thyroid carcinoma with clinicopathologic correlation. // Hum. Pathol.-2008.-V.39.-N.l 1.-P. 1656−63.
- Schmid KW., Farid NR. How to define follicular thyroid carcinoma. // Virchows Arch.-2006.-V.448.-N.4.-P.3 85−93.
- Serra S., Asa SL. Controversies in thyroid pathology: the diagnosis of follicular neoplasms. // Endocr. Pathol.-2008.-V.19.-N.3.-P.156−65.
- Sheils O.M., O’eary J.J., Uhlmann V. et al. Ret/PTC-1 activation in Hashimoto’s thyroiditis. // Int. J. Surg. Pathol. 2000. — V. 8. — P. 185−189.
- Sheu SY., Grabellus F., Schwerhein S. et al. Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumors. //Br. J. Cancer.- 2010.-V.102.-N.2.-P.376−82.
- Shibru D., Hwang J., Khanafshar E. et al. Does the 3-gene diagnostic assay accurately distinguish benign from malignant thyroid neoplasms? // Cancer. -2008. V. 113. — N. 5. — P. 930−935.
- Stolf B.S., Santos M.M.S., Simao D.F. et al. Class distinction between follicular adenomas and follicular carcinomas of the thyroid gland on the basis of their signature expression. // Cancer. 2006. — V. 106. — P. 1891−1900.
- Strugis E.M., Li G. Molecular epidemiology of papillary thyroid cancer: in search of common genetic associations. // Thyroid.-2009.-V.19.-N.10.-P.1031−4.
- Suster S. Thyroid tumors with a follicular growth pattern: problems in differential diagnosis. // Arch. Pathol. Lab. Med.-2006.-V.130.-N.7.-P.984−8.
- Takano Т., Miyauchi A., Yoshida H. et al. Decreased relative expression level of trefoil factor 3 mRNA to galectin-3 mRNA distinguishes thyroid follicular carcinoma from adenoma. // Cancer Let. 2005. — V. 219. — P. 9196.
- Thomas G.A., Williams E.D. Chernobyl thyroid tumor tissue and nucleic acid bank. //Rad. Res. -2001. -V. 156. P. 333.
- Vasko W., Gaudart J., Allasia C. et al. Thyroid follicular adenomas may display features of follicular carcinoma and follicular variant of papillary carcinoma. //Eur. J. Endocrinol. -2004.-V.151.-N.6.-P.779−86.
- Volante M., Bozzalla-Cassione F., De Pompa R. et al. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. // Virchows Arch.- 2004. V. 445. — N. 2. — P. 183−188.
- Volante M., Rapa I., Gandhi M. et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. // J. Clin. Endocrinol. Metab.-2009.- V.94.-N.12.-P.4735−41.
- Volante M., Bozzalla-Cassione F., Orlandi F., Papotti M. Diagnostic role of galectin-3 in follicular thyroid tumors. // Virchows Arch. 2004. — V. 444. -N. 4.-P. 309−312.
- Vriens MR., Schreinemakers JM., Suh I et al. Diagnostic markers and prognostic factors in thyroid cancer. // Future Oncol.-2009.-V.5.-N.8.-P.1283−93.
- Weber F., Eng C. Gene-expression profiling in differentiated thyroid cancera viable strategy for the practice of genomic medicine. // Future Oncol. -2005. V. 1. — N. 4. — P. 497−510.
- Weber F., Shen L., Aldred M.A. et al. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination. // J. Clin. Endocrinol. Metab. 2005. — V. 90. — N. 5. — P. 2512−2521.
- Weber K.B., Shroyer K.R., Heinz D.E. et al. The use of a combination of galectin-3 and thyroid peroxidase for the diagnosis and prognosis of thyroid cancer. // Am. J. Clin. Pathol. 2004. — V. 122. — N. 4. — P. 524−531.
- Williams E.D. Guest editorial: two proposals regarding the terminology of thyroid tumors. // Int. J. Surg. Pathol. 2000. — V. 8. — N. 3. — P. 181−183.
- Williams E.D. Radiation carcinogenesis: lessons from Chernobyl. // Oncogene.2008.-V.27.-Suppl.2.-P.9−18.
- Wirtschafter A., Schmidt R., Rosen D. et al. Expression of the RET/PTC fusion gene as a marker for papillary carcinoma in Hashimoto’s thyroiditis. // Laryngoscope. 1997. — V. 107. — P. 95−100.
- Zeiger MA., Dackiw AP. Follicular thyroid lesions, elements that affect both diagnosis and prognosis. // J. Surg. Oncol.-2005.-V.89.-N.3.-P. 108−13.
- Zhao J., Leonard C., Gemsenjager E. et al. Differentiation of human follicular thyroid adenomas and carcinomas by gene expression profiling. // Oncol. Rep. 2008. — V. 19. — N. 2. — P. 329−337.
- Zhao Z., Wei Q., Zhao Y. et al. Genetic copy number alterations and IL-13 expression differences in papillary thyroid cancers and benign nodules.-Endocrine.-2009.-V.36.-N. 1 .-P. 155−60.